JETEMA, Co., Ltd. (216080.KQ)

KRW 15130.0

(-2.64%)

Total Assets Summary of JETEMA, Co., Ltd.

  • JETEMA, Co., Ltd.'s latest annual total assets in 2023 was 252.14 Billion KRW , up 33.87% from previous year.
  • JETEMA, Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 227.1 Billion KRW , down -0.42% from previous quarter.
  • JETEMA, Co., Ltd. reported annual total assets of 188.35 Billion KRW in 2022, up 27.33% from previous year.
  • JETEMA, Co., Ltd. reported annual total assets of 147.92 Billion KRW in 2021, up 121.25% from previous year.
  • JETEMA, Co., Ltd. reported quarterly total assets of 228.05 Billion KRW for 2024 Q1, down -9.56% from previous quarter.
  • JETEMA, Co., Ltd. reported quarterly total assets of 188.46 Billion KRW for 2023 Q1, up 0.06% from previous quarter.

Annual Total Assets Chart of JETEMA, Co., Ltd. (2023 - 2017)

Historical Annual Total Assets of JETEMA, Co., Ltd. (2023 - 2017)

Year Total Assets Total Assets Growth
2023 252.14 Billion KRW 33.87%
2022 188.35 Billion KRW 27.33%
2021 147.92 Billion KRW 121.25%
2020 66.86 Billion KRW 7.34%
2019 62.28 Billion KRW 21.45%
2018 51.28 Billion KRW 170.37%
2017 18.96 Billion KRW 0.0%

Peer Total Assets Comparison of JETEMA, Co., Ltd.

Name Total Assets Total Assets Difference
HLB Co., Ltd. 751.72 Billion KRW 66.457%
iNtRON Biotechnology, Inc. 98.61 Billion KRW -155.689%
BINEX Co., Ltd. 257.01 Billion KRW 1.893%
Bioneer Corporation 315.48 Billion KRW 20.077%
Anterogen.Co.,Ltd. 149.43 Billion KRW -68.737%
MEDIPOST Co., Ltd. 449.39 Billion KRW 43.892%
CrystalGenomics, Inc. 243.11 Billion USD -3.715%
Helixmith Co., Ltd 227.27 Billion KRW -10.941%
Chabiotech Co.,Ltd. 1725.57 Billion KRW 85.388%
Medy-Tox Inc. 611.62 Billion KRW 58.774%
Peptron, Inc. 52.49 Billion KRW -380.317%
Amicogen, Inc. 467.09 Billion KRW 46.018%
Genexine, Inc. 376.58 Billion KRW 33.044%
HLB Therapeutics Co.,Ltd. 200.79 Billion KRW -25.574%
LegoChem Biosciences, Inc. 189.5 Billion KRW -33.058%
ALTEOGEN Inc. 256.09 Billion KRW 1.544%
PharmaResearch Co., Ltd. 535.28 Billion KRW 52.894%
SillaJen, Inc. 76.71 Billion KRW -228.681%
OliX Pharmaceuticals,Inc 102.82 Billion KRW -145.219%
Genomictree Inc. 132.84 Billion KRW -89.807%
MedPacto, Inc. 80.47 Billion KRW -213.326%
D&D Pharmatech 79.2 Billion KRW -218.353%
EASY BIO,Inc. 172.04 Billion KRW -46.562%
GI Innovation, Inc. 81.34 Billion KRW -209.991%